- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01848964
Analyzing Stump-socket Interface Pressure to Improve Gait in Above-knee Amputee
Peut-on améliorer la Marche de l'amputé fémoral en Guidant la Correction prothétique Par l'Analyse Des Pressions Dans l'emboîture ?
This study aims at evaluating the relation between quality of the interface between the stump and the prosthesis, and the quality of gait in above-knee amputees.
The hypothesis is that an adapted prosthesis allowing an efficient gait in above-knee amputees corresponds to an homogeneous pressure distribution pattern onto the stump.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Forty amputee patients will be evaluated for satisfaction with the prosthesis, pressure repartition pattern and functional capabilities.
Pressure at the stump-socket interface will be recorded using a set of 14 single cells sensors placed in predefined positions onto the stump. Pattern of pressure will be measured in four tasks: sitting posture, standing posture, gait initiation, and gait at preferred velocity.
Reproducibility of the pressure repartition pattern will be analyzed by repeating gait and standing posture task in the first 15 patients included.
In patients whom prosthesis has been modified on the basis on the first pressure measurement (pressure peak and bad functional capacities), a new pressure measurement will be repeated 2-8 weeks apart.
Postural and gait abilities will be also assessed in 40 age/gender matched non-amputated subjects to serve as control data.
Study Type
Enrollment (Actual)
Phase
- Phase 2
- Phase 1
Contacts and Locations
Study Locations
-
-
-
Grenoble, France, 38000
- University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Amputee patients:
Inclusion Criteria:
- unilateral transfemoral amputation
- use of a prosthesis with a "contact" socket
Exclusion Criteria:
- neurological or muscular disorder likely to impair walking capabilities
- Mini Mental State Examination below 24/30
- Healthy subjects :
Exclusion Criteria:
- neurological or muscular disorder likely to impair walking capabilities
- Mini Mental State Examination below 24/30
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Evaluation
First, the assessment will be performed to evaluate the relationship between pressure repartition pattern, clinical evaluation and motor capabilities. All the patients and volunteers will be concerned by this first part. A second part will be conducted in 15 amputees within the 40 patients. Assessments of pressure pattern during gait and standing will be repeated two times: by the same investigator and by a different investigator, in order to test intra- and inter-evaluator reproducibility. After the first assessment, the prosthesis may be modified in order to solve clinical problems. In that case, a new assessment will be proposed 2 to 8 weeks after in order to test the effect of the prosthesis modification on pressure pattern, gait, posture and clinical parameters. |
Clinical examination will include stump pain, wound, scar and unusual shape. Questionnaire will include satisfaction scale (SatPro), comfort scale (SCE), and functional scale (PPA-LCI) After installing the sensors on the stump, the patient will put his prosthesis on and will perform the following tasks: gait, sitting and standing posture and gait initiation. Pressure repartition at the stump-socket interface will be assessed with the 14 flat sensors. Gait parameters will be assessed with the OptoGait device. Standing posture and gait initiation parameters will be assessed with a force-plate. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Two minute Walking Test
Time Frame: At inclusion (baseline) for all patients
|
Maximal distance(m)walked during 2 minutes (one trial)
|
At inclusion (baseline) for all patients
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Variation coefficient of maximal pressures during gait
Time Frame: At inclusion (Baseline) for all patients
|
Calculated on the basis of 10 walking trials of 10 meters. The maximal pressure will be measured at each step for each sensor. The mean maximal pressure is calculated for each of the 14 sensors. The variation coefficient is calculated between these 14 values (variation coefficient = standard deviation/mean) A low variation coefficient of pressure is supposed to represent an homogeneous repartition of the pressure in the prosthesis. |
At inclusion (Baseline) for all patients
|
|
Change in two minutes walk tests between Baseline and 5 Weeks
Time Frame: Five weeks (W5) in average after inclusion in patients in whom the prosthesis will be modified
|
If a modification of the prosthesis is required and performed on the basis of the first assessment (at inclusion), a new assessment with the modified prosthesis is performed 5 weeks later (from 2 to 8 weeks). Change in walking capabilities is assessed by calculating the difference between results of the two minute walk test at inclusion and at 5 weeks. |
Five weeks (W5) in average after inclusion in patients in whom the prosthesis will be modified
|
|
Change in the variation coefficients of maximal pressures between Baseline and 5 Weeks
Time Frame: 5 Weeks in average (2 and 8 weeks) after the inclusion in patients in whom the prosthesis will be modified
|
If a modification of the prosthesis is required and performed on the basis of the first assessment (at inclusion), a new assessment with the modified prosthesis is performed 5 weeks later (from 2 to 8 weeks). Change of repartition pattern will be assessed by calculating the difference between the variation coefficient before and after the prosthesis modification. |
5 Weeks in average (2 and 8 weeks) after the inclusion in patients in whom the prosthesis will be modified
|
|
Gait spatial and temporal parameters
Time Frame: At inclusion for all patients
|
Calculated based on 10 walking trial of 10 meters.
Speed, step length of the prosthetic and non-amputated leg and standing time on the prosthetic and non-amputated leg
|
At inclusion for all patients
|
|
Variation coefficient of maximal pressure during standing posture
Time Frame: At inclusion for all patients
|
Calculated based on 4 standing trial of 30 seconds.
The calculation is the same as for gait, but the mean pressure during the postural trial will be used instead of the maximal pressure during the step.
|
At inclusion for all patients
|
|
Reproducibility of the Variation Coefficients of maximal pressures
Time Frame: At baseline
|
At inclusion (baseline), the measurements of pressure repartition pattern in gait and standing posture tasks will be repeated twice, in order to test inter- and intra-evaluator reproducibility.
|
At baseline
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Occurrence of pain, dyscomfort, or skin wound due to the measurement system
Time Frame: at baseline
|
By structured interview, visual analogic pain scale, and clinical examination at the end of the baseline assessment.
|
at baseline
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2013-A00219-36
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lower Limb Amputation Above Knee (Injury)
-
Sint MaartenskliniekCompletedLower Limb Amputation Above Knee (Injury) | Lower Limb Amputation KneeNetherlands
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR)RecruitingLower Limb Amputation Below Knee (Injury) | Lower Limb Amputation Above Knee (Injury) | Amputation | Behavior | Lower Limb Amputation KneeCanada
-
Otto Bock Healthcare Products GmbHCompletedLower Limb Amputation Below Knee (Injury) | Lower Limb Amputation Above Knee (Injury) | Lower Limb Amputation KneeUnited States
-
University of Nevada, Las VegasUnited States Department of Defense; National Institutes of Health (NIH); University... and other collaboratorsRecruitingLower Limb Amputation Below Knee (Injury) | Lower Limb Amputation Above Knee (Injury) | Amputation | Lower Limb Amputation Knee | Lower Limb Amputation at Ankle (Injury) | Lower Limb Amputation at Hip (Injury)United States
-
Institution Nationale des InvalidesUnion de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord... and other collaboratorsCompletedLower Limb Amputation Above Knee (Injury) | AmputationFrance
-
Mayo ClinicAmerican Orthotic and Prosthetic AssociationCompletedLower Limb Amputation Above Knee (Injury)United States
-
Proteor GroupCompletedLower Limb Amputation Above Knee (Injury)France
-
Vrije Universiteit BrusselUnknownLower Limb Amputation Above Knee (Injury)Belgium
-
Proteor GroupRecruitingLower Limb Amputation Above Knee (Injury)France
-
Vrije Universiteit BrusselÖssur Iceland ehfCompletedLower Limb Amputation Above Knee (Injury)Belgium
Clinical Trials on Clinical and instrumented measurements
-
Faculty of Dental Medicine for GirlsActive, not recruitingPlaque | Patient Satisfaction | Post Operative Pain | Caries, CervicalEgypt
-
Pamukkale UniversityCompletedDiabetes Mellitus, Type 2 | Periodontitis | Coronary Heart Disease | Arterial StiffnessTurkey
-
Jiarong Chen, MDUnknownThe Association of hsCRP and Radiotherapy-Induced Toxicity in Patients With Nasopharyngeal CarcinomaHead and Neck Cancer | Nasopharyngeal Carcinoma | Toxicity Due to Radiotherapy
-
Pierre Fabre Dermo CosmetiqueTerminatedDermatitis, AtopicFrance
-
Necmettin Erbakan UniversityNot yet recruitingSmoking | Periodontitis | Periodontal Diseases
-
Aydin Adnan Menderes UniversityCompleted
-
Sys2DiagCentre National de la Recherche Scientifique, FranceRecruitingSport Related ConcussionFrance
-
Kenvue Brands LLCCompletedSensitive Skin | Non-sensitive SkinUnited States
-
Necmettin Erbakan UniversityNot yet recruitingImpact of Smoking on Salivary Interleukin (IL)-39, IL-41, IL-1β, TNF-α Levels in Periodontal DiseaseSmoking | Periodontal Diseases | Periodontitis, Adult